This article primarily discusses the possible applications of nano-preparations in Candida albicans infections from the following points of view: Nano-preparations for anti-biofilm therapy
As shown in Scheme 8
As shown in Figures 8AD, Akt phosphorylation levels exhibited significant negative correlations with Cox IV activity (R 2 = 0.73, 95% CI [0.97, 0.44], P = 0.0033), CPT-1B expression (R 2 = 0.84, 95% CI [0.98, 0.64], P = 0.0005), and ATP levels (R 2 = 0.65, 95% CI [0.96, 0.30], P = 0.0091), but a positive correlation with ROS levels (R 2 = 0.86, 95% CI [0.68, 0.98], P = 0.0003)
| | Aggressive Stack | 12.515mg weekly (therapeutic dose) | 100mg daily | Weekly + daily | Maximal incretin effect + maximal NNMT inhibition | 1624 weeks | Highest theoretical synergy but also highest metabolic stress
Overall, the number of GLP-1 prescriptions increased sevenfold, from about 1 million in 2019 to over 8 million in 2024